JOIN FOR FREE
Search
mobile-logo
 

N4P Tag

N4 Pharma PLC – N4P – Interim Results

17th September 2020

N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for vaccines and cancer treatments, announces its unaudited interim results for the six months ended 30...

Read More

N4 Pharma PLC – Covid-19 Project Update

28th May 2020

Further to the Company's announcement on 16 April 2020, N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased...

Read More

N4 Pharma PLC – Final Results

25th February 2020

N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to announce its audited results for the year...

Read More

N4 Pharma PLC – Interim Results

18th September 2019

N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for vaccines and cancer treatments, announces its unaudited interim results for the six months ended 30...

Read More

N4 Pharma PLC – AGM Statement

19th June 2019

N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for vaccines and cancer treatments, announces that at its annual general meeting, being held later today, Nigel...

Read More

N4 Pharma PLC – Final Results

14th May 2019

N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for vaccines and cancer treatments, announces the Company's audited results for the year ended 31 December 2018....

Read More

N4 Pharma PLC – Nuvec® Research update

15th April 2019

N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for vaccines and cancer treatments, provides an update on the development of Nuvec®....

Read More

N4 Pharma PLC – Nuvec® Research update

9th April 2019

N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for vaccines and cancer treatments, provides an update on the development of Nuvec®....

Read More

N4 Pharma PLC – Nuvec® research update

28th November 2018

N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing a novel delivery system for vaccines and cancer treatments, today announces a further update on the latest key research findings...

Read More